Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Stephen Kim appointed as Chief Legal Officer & General Counsel

Avicanna has appointed Stephen Kim as Avicanna’s Chief Legal Officer & General Counsel.

Mr. Kim comes with over twenty years of legal experience with highly regulated and innovative industries. He has significant pharmaceutical industry experience and is very familiar with the complex overlay of corporate, commercial, IP, governance, compliance, and regulatory considerations associated with development, approval, and launch of multiple pharmaceutical products, which he has executed in the US, Canada, and globally. 

Prior to joining Avicanna, Mr. Kim held various roles of progressive responsibility at global biotechnology and pharmaceutical companies including Bayer Inc., Celgene Corporation, and Indivior Inc., and also held roles as an associate with leading US and International law firms in New York City and Toronto. Mr. Kim graduated with a US law degree from University of Detroit Mercy (JD) and a Canadian law degree from the University of Windsor (LLB).

“I am delighted to be joining Avicanna at such an exciting time and looking forward to partnering and working with the dynamic and visionary Management Team and with the accomplished and experienced members of the Board of Directors.” Stephen Kim commented “With my background and experience in domestic and cross-border transactions, as well as pharmaceutical product development, approval, and launch, I am particularly excited about the Company’s work in the areas of evidence-based and pharmaceutical products and global business.” 

“We are thrilled to bring someone of Mr. Stephen Kim’s calibre onboard as we evolve into the next phase of commercialization and development of our pharmaceutical pipeline. Stephen’s experience and track record coupled with his alignment of vision with the Management Team is precisely what the Company needs to achieve its growth potential,” Aras Azadian, Chief Executive Officer, commented.

Mr. Kim will join the Company at his role as the Chief Legal Officer on January 17, 2022, where he will oversee all legal and regulatory affairs at a global level.

For more information:
Avicanna
info@avicanna.com  
avicanna.com  

Publication date: